Cocrystal Pharma earnings were -$9.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest COCP earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.2M, up 37.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, COCP reported annual earnings of -$8.8M, with -49.5% growth. The next COCP earnings date is Nov 13, 2026.
What were Cocrystal Pharma's earnings last quarter?
On COCP's earnings call on Aug 13, 2026, Cocrystal Pharma (NASDAQ: COCP) reported Q2 2026 earnings per share (EPS) of -$0.23, up 15% year over year. Total COCP earnings for the quarter were -$3.16 million. In the same quarter last year, Cocrystal Pharma's earnings per share (EPS) was -$0.20.
The next COCP earnings call is Nov 13, 2026. Add COCP to your watchlist to be reminded of Cocrystal Pharma's next earnings date.
Is Cocrystal Pharma profitable or losing money?
As of the last Cocrystal Pharma earnings report, Cocrystal Pharma is currently losing money. Cocrystal Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$9.94 million, a 20.88% decrease year over year.
What was COCP's earnings growth in the past year?
As of Cocrystal Pharma's earnings date in Aug 13, 2026, Cocrystal Pharma's earnings has grown year over year. COCP earnings in the past year totalled -$9.94 million.
What are Cocrystal Pharma's earnings expectations?
The current EPS estimate for Cocrystal Pharma's earnings report in Nov 13, 2026 is -$0.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.